THE PREMISE: The prostate biopsy procedure has become an increasingly important diagnostic tool for prostate cancer detection. Prostate cancer is the most common malignancy among men worldwide. Prostate cancer claims the lives of almost 40,000 men every year at significant loss to society, family, and fiscal interests. The benefit of the test notwithstanding, 70 - 75% of all prostate biopsies are negative and therefore theoretically unnecessary. Thus, minimally, three-fourths of all men with only an elevated PSA (prostate specific antigen) are subjected needlessly to an expensive, painful, frightening, and humiliating test. In an effort to improve the positive predictability of the prostate biopsy procedure for prostate cancer, as well as to eliminate needless future biopsies, I submit that the successful improvement of prostatitis will lower the PSA. A lower PSA will diminish the enthusiasm for an academically aggressive program for additional biopsies. Recruitment has begun for a randomized, double blind study using the patented all natural prostate formula (PEENUTS®), a formula that holds promise to take men out of harms way by successfully improving and/or eliminating objective signs of prostatitis. This approach is expected to be patient and physician friendly. Few physicians want to continue to biopsy a patient, when an alternative approach can be implemented, saving the health care system millions of dollars. This approach does not falsely lower the PSA, but rather lowers the PSA by virtue of decreasing the inflammation that primarily stimulates the PSA rise and concern as a source for future prostate cancer growth. TO QUALIFY, MEN MUST MEET THREE CONDITIONS:
Questions regarding the study from interested patients or urologists may be directed to:
|